Previously, we showed that progesterone (P4) inhibits proliferation and migration of rat aortic smooth muscle cells (RASMCs). The P4-induced migration inhibition in RASMCs resulted from suppression of the Ras homolog gene family, member A (RhoA) activity mediated by cSrc activation. We also observed that P4 increased the formation of p27-RhoA complex in RASMCs. The aim of this study was to further study the involvement of p27 in P4-induced migration inhibition in RASMCs. Treatment with P4 (50 nM) increased the level of p27 protein in RASMCs. Knockdown of p27 abolished the P4-induced increases of the levels of p27 protein and decreases of cell migration in RASMCs. We conducted Western blot analyses and applied pharmacologic inhibitors to delineate the signaling pathway involved in the P4-induced p27 up-regulation and migration inhibition in RASMCs. Our data suggest that P4 increased the levels of p27 in RASMCs through activating the cSrc/AKT/ERK 2/p38 pathway mediated by nongenomic progesterone receptor. The findings of the present study highlight the molecular mechanisms underlying P4-induced migration inhibition in RASMCs.
Pubmed ID: 24479887 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets Mapk3
View all literature mentionsThis monoclonal targets p27Kip1
View all literature mentionsThis monoclonal targets Src
View all literature mentionsThis polyclonal targets MAP Kinase (ERK-1 ERK-2) antibody produced in rabbit
View all literature mentionsThis monoclonal targets α-tubulin
View all literature mentionsThis monoclonal targets NFKBIA
View all literature mentionsThis monoclonal targets NFKBIA
View all literature mentionsThis monoclonal targets Genetic locus: RELA (human) mapping to 11q13.1; Rela (mouse) mapping to 19 A.
View all literature mentionsThis polyclonal targets AKT3
View all literature mentionsThis polyclonal targets AKT1, AKT3
View all literature mentions